Research

 

Research Interests:

Uddin Lab is focused on the development of molecular imaging technologies including optical imaging, optical coherence tomography (OCT) and nano-scale engineering to identify molecular targets for early disease-detection and treatments in ophthalmology, vascular medicine and oncology.

Dr. Uddin is currently using optical imaging techniques and nanotechnology-based approaches for diagnosis and drug delivery in preclinical models of diabetic retinopathy (DR), retinopathy of prematurity (ROP), retinal vein occlusion (RVO) and age-related macular degeneration (AMD).

Dr. Uddin is highly collaborative and his long-term collaborators are Dr. John S. Penn and Dr. Craig Duvall.